## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.35 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($157.49)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Quantbot Technologies LP Sells 14,563 Shares of Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251206T112219 | Somewhat-Bullish | Relevance: 99%
- Quantbot Technologies LP significantly reduced its stake in Raymond James Financial, Inc. (NYSE:RJF) by 47.3% in Q2, selling 14,563 shares and holding 16,210 shares valued at approximately $2.486 million. This reduction comes as Raymond James Financial reported strong quarterly earnings, beating analyst expectations with an EPS of $3.11 and a 7.7% year-over-year revenue increase to $3.73 billion, while also raising its quarterly dividend to $0.54 per share. Despite the share reduction by Quantbot, other institutional investors have shown varied activities, with several increasing their holdings in the financial services provider.

**2. Marshall Wace LLP Acquires 390,821 Shares of Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251207T111346 | Bullish | Relevance: 98%
-  Marshall Wace LLP significantly increased its stake in Raymond James Financial, Inc. ($RJF) by 824.7% in Q2, purchasing 390,821 additional shares to now own a total of 438,213 shares valued at approximately $67.21 million. Raymond James Financial ($RJF) recently beat earnings expectations, reporting EPS of $3.11 against an anticipated $2.83, and has increased its quarterly dividend to $0.54 per share. Several other hedge funds have also adjusted their positions in the company, with 83.83% of the stock currently held by institutional investors.

**3. Is Raymond James Financial Stock Underperforming the Dow?**
- Source: Barchart.com | 20251209T125157 | Neutral | Relevance: 98%
-  Raymond James Financial (RJF) has underperformed the Dow Jones Industrials Average ($DOWI) over the past three months, year-to-date, and over the past 52 weeks. Despite reporting stronger Q4 2025 results and positive analyst sentiment with a "Moderate Buy" rating, the stock has struggled against the broader market while still outperforming rival Blackstone Inc.

**4. Amundi Has $62 Million Position in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251209T083449 | Somewhat-Bullish | Relevance: 97%
-  Amundi significantly reduced its stake in Raymond James Financial, Inc. by 47.7% during the second quarter, now holding 391,970 shares valued at $62 million. Despite this reduction, several other institutional investors increased their positions in RJF. Analysts have provided mixed ratings, with a consensus "Hold" and an average target price of $177.20 for Raymond James Financial.

**5. Raymond James Financial's (NYSE:RJF) Dividend Will Be Increased To $0.54**
- Source: Simply Wall Street | 20251207T131753 | Bullish | Relevance: 97%
-  Raymond James Financial (NYSE:RJF) is increasing its dividend to $0.54, payable on January 16th, though the yield remains low at 1.3%. The company's earnings comfortably cover the dividend, with EPS forecast to grow by 46.2% over the next year, leading to a sustainable projected payout ratio of 15%. This, combined with a strong track record of dividend growth, makes Raymond James Financial an attractive income stock.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 15 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.35 suggests fair value with growth premium. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.7B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.35 |
| Forward P/E | 12.2 |
| Current P/E | 13.6 |
| YoY Growth | 11.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.1% to 1.7% (+4.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.3pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.24), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.68% (CS: 68) | Neutral |
| RSI_14 | 60.8 | Neutral |
| MACD Histogram | 1.24 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.061x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $164.19
- **Stop Loss:** $157.49 (4.1% risk)
- **Target:** $177.59 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 149
- **Position Value:** $24,464.31
- **Portfolio %:** 24.46%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*